Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Aggressive Hydration With Lactated Ringer's Solution Versus Plasma Solution for the Prevention of Post ERCP Pancreatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aggressive hydration with Lactated Ringer's solution versus Plasma-Lyte for the prevention of post-ERCP pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactated Ringer's solution (Ringer's lactate solution)
  • Plasma-Lyte (Plasma-Lyte)

Snippet

Sponsor: Do Hyun Park | Conditions: Pancreatic Disease | Phase 4 | Status: COMPLETED